Sunshine Biopharma Inc. Accounts Receivable
Sunshine Biopharma Inc. (SBFM) had Accounts Receivable of $4.04 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $4.04M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $4.01M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $3.46M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $4.16M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.04M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.01M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $3.46M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $4.16M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.59M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $3.45M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.87M 10-K · filed 2026-04-03 | |
| 2024-09-30 | $3.22M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $3.97M 10-Q/A · filed 2024-08-20 | |
| 2024-03-31 | $2.83M 10-Q · filed 2024-05-20 | |
| 2023-12-31 | $2.55M 10-K · filed 2025-04-01 | |
| 2023-09-30 | $2.03M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.01M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.79M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.91M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $22.00 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $24.00 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $24.00 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $7.80K 10-K · filed 2023-04-04 | |
| 2021-09-30 | $1.13K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $1.92K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $0.00 10-Q/A · filed 2020-08-31 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-18 | |
| 2019-12-31 | $430.00 10-K · filed 2021-03-30 | |
| 2019-06-30 | $1.02K 10-Q · filed 2019-08-15 | |
| 2019-03-31 | $119.20K 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $0.00 10-K · filed 2020-05-01 | $94.95K 10-K · filed 2019-04-12 |
| 2018-09-30 | $102.89K 10-Q · filed 2018-11-16 | |
| 2018-06-30 | $108.23K 10-Q · filed 2018-08-17 | |
| 2018-03-31 | $92.39K 10-Q · filed 2018-05-22 | |
| 2017-12-31 | $0.00 10-K · filed 2019-04-12 | |
| 2016-09-30 | $1.01K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $77.00K 10-Q · filed 2016-08-16 | |
| 2016-03-31 | $103.16K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $3.11K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $1.93K 10-Q · filed 2015-08-06 | |
| 2014-12-31 | $0.00 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |